AQP4 and myeloid sarcoma: Magnetic resonance imaging (MRI) and clinical data were available for 22 anti-AQP1-seropositive, anti-AQP4-seronegative patients, consisting of 17 with suspected NMOsd and 5 MS patients (shown in Figure 1).